ACHE and Alzheimer disease: In an AD model (Wistar rats injected with STZ in the lateral ventricle), ginsenoside Rg5 was observed to dose-dependently inhibit AChE and activate ChAT, and it improved learning and memory in rats in the MWM test (Chu et al., 2014).